BioSig Technologies Inc. Expands into Blockchain with Strategic Acquisitions
BioSig Technologies Inc., a medical technology company specializing in signal processing solutions for cardiac catheter ablations, has recently made significant strides in the blockchain and financial technology sectors. The company, which operates in the health care equipment and supplies industry, is listed on the Nasdaq with a market capitalization of $819.6 million. Despite a challenging financial year, evidenced by a negative price-to-earnings ratio of -9.4 and a close price of $5.23 as of July 10, 2025, BioSig is actively pursuing growth through strategic acquisitions and partnerships.
On July 14, 2025, BioSig announced its engagement with CXG to acquire a FINRA/SEC-registered broker-dealer. This acquisition is a pivotal move to expand BioSig’s operations in publicly traded real-world asset (RWA) tokenization. The acquisition aims to position Streamex, a company recently merged with BioSig, as one of the first NASDAQ-listed issuers of RWA tokens in the U.S. compliant with SEC and FINRA regulations. This strategic initiative underscores BioSig’s commitment to integrating blockchain technology into its business model, potentially opening new revenue streams and enhancing its market presence.
In addition to the broker-dealer acquisition, BioSig has also engaged in a gold token launch, further solidifying its foray into the digital asset space. This move aligns with the company’s broader strategy to leverage blockchain technology to innovate within the healthcare sector.
Earlier in the week, on July 11, 2025, BioSig and Streamex announced the appointment of Russell Starr as a Strategic Advisor. Mr. Starr, a defi expert with extensive experience in capital markets and transformative deal-making, is expected to provide valuable insights and guidance as BioSig navigates the complex landscape of decentralized finance (defi) and traditional financial markets.
These developments highlight BioSig Technologies Inc.’s strategic pivot towards blockchain and financial technology, aiming to diversify its offerings and capitalize on emerging trends in digital assets. As the company continues to integrate these new technologies, it remains focused on enhancing its core medical technology solutions while exploring innovative avenues for growth.